CMCDI (133) Announces RMB 15 Million Investment in Neuracle Technology

Bulletin Express

Dec 01, 2025

China Merchants China Direct Investments Limited (CMCDI, Stock Code: 133) disclosed that its wholly-owned subsidiary, Shenzhen Tian Zheng Investment Co., Ltd. (Tian Zheng), entered into a share purchase agreement and other relevant agreements on 28 October 2025. The agreements involve Neuracle Technology (Shanghai) Co., Ltd. (Neuracle Technology), a high-tech enterprise centered on proprietary brain-computer interface (BCI) technology.

According to the announcement, Tian Zheng agreed to commit RMB 15 million in Neuracle Technology’s Series E funding and completed this capital contribution on 7 November 2025. Founded in November 2011, Neuracle Technology specializes in the research, development, production, sales, and technical services of BCI systems. Its solutions support various domains, including neuroscience, psychology, and rehabilitation for neurological disorders.

The announcement states that this move increases CMCDI’s involvement in medical projects and further optimizes its investment portfolio.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1127585831"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1127585831\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1127585831?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-01 16:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127585831","market":"us","top_or_hot":-1,"title":"CMCDI (133) Announces RMB 15 Million Investment in Neuracle Technology","media":"Bulletin Express","content":"<p>China Merchants China Direct Investments Limited (CMCDI, Stock Code: 133) disclosed that its wholly-owned subsidiary, Shenzhen Tian Zheng Investment Co., Ltd. (Tian Zheng), entered into a share purchase agreement and other relevant agreements on 28 October 2025. The agreements involve Neuracle Technology (Shanghai) Co., Ltd. (Neuracle Technology), a high-tech enterprise centered on proprietary brain-computer interface (BCI) technology.</p>\n<p>According to the announcement, Tian Zheng agreed to commit RMB 15 million in Neuracle Technology’s Series E funding and completed this capital contribution on 7 November 2025. Founded in November 2011, Neuracle Technology specializes in the research, development, production, sales, and technical services of BCI systems. Its solutions support various domains, including neuroscience, psychology, and rehabilitation for neurological disorders.</p>\n<p>The announcement states that this move increases CMCDI’s involvement in medical projects and further optimizes its investment portfolio.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CMCDI (133) Announces RMB 15 Million Investment in Neuracle Technology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCMCDI (133) Announces RMB 15 Million Investment in Neuracle Technology\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-01 16:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Merchants China Direct Investments Limited (CMCDI, Stock Code: 133) disclosed that its wholly-owned subsidiary, Shenzhen Tian Zheng Investment Co., Ltd. (Tian Zheng), entered into a share purchase agreement and other relevant agreements on 28 October 2025. The agreements involve Neuracle Technology (Shanghai) Co., Ltd. (Neuracle Technology), a high-tech enterprise centered on proprietary brain-computer interface (BCI) technology.</p>\n<p>According to the announcement, Tian Zheng agreed to commit RMB 15 million in Neuracle Technology’s Series E funding and completed this capital contribution on 7 November 2025. Founded in November 2011, Neuracle Technology specializes in the research, development, production, sales, and technical services of BCI systems. Its solutions support various domains, including neuroscience, psychology, and rehabilitation for neurological disorders.</p>\n<p>The announcement states that this move increases CMCDI’s involvement in medical projects and further optimizes its investment portfolio.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00133","symbol_name":"招商局中国基金","start_time":0,"source_url":"","article_id":"1127585831","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127585831","pubTimestamp":1764578677,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Merchants China Direct Investments Limited (CMCDI, Stock Code: 133) disclosed that its wholly-owned subsidiary, Shenzhen Tian Zheng Investment Co., Ltd. (Tian Zheng), entered into a share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00133":"招商局中国基金"},"translate_title":"CMCDI(133)宣布1500万元投资Neuracle科技","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00133":1},"content_text":"China Merchants China Direct Investments Limited (CMCDI, Stock Code: 133) disclosed that its wholly-owned subsidiary, Shenzhen Tian Zheng Investment Co., Ltd. (Tian Zheng), entered into a share purchase agreement and other relevant agreements on 28 October 2025. The agreements involve Neuracle Technology (Shanghai) Co., Ltd. (Neuracle Technology), a high-tech enterprise centered on proprietary brain-computer interface (BCI) technology.\nAccording to the announcement, Tian Zheng agreed to commit RMB 15 million in Neuracle Technology’s Series E funding and completed this capital contribution on 7 November 2025. Founded in November 2011, Neuracle Technology specializes in the research, development, production, sales, and technical services of BCI systems. Its solutions support various domains, including neuroscience, psychology, and rehabilitation for neurological disorders.\nThe announcement states that this move increases CMCDI’s involvement in medical projects and further optimizes its investment portfolio.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}